# Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Canonical URL: https://biopharmsignal.com/news/OM/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-21643aa5
Ticker: OM
Company: Outset Medical
Source: Outset Medical
Published: 2026-07-02 20:05 EST
Original Source URL: https://investors.outsetmedical.com/news-releases/news-release-details/outset-medical-reports-inducement-grant-under-nasdaq-listing-1
## Summary

SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of

## Article Body
SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of
## Recent Company News
- 2026-07-02 20:05 EST — [Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/OM/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-21643aa5) — Source: Outset Medical
- 2026-06-25 13:46 EST — [Outset Medical to Present at RBC Global Healthcare Conference](https://biopharmsignal.com/news/OM/outset-medical-to-present-at-rbc-global-healthcare-conference) — Source: Outset Medical
- 2026-06-25 13:46 EST — [Outset Medical Reports First-Quarter Results](https://biopharmsignal.com/news/OM/outset-medical-reports-first-quarter-results) — Source: Outset Medical
- 2026-06-25 13:46 EST — [New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System](https://biopharmsignal.com/news/OM/new-research-demonstrates-the-advantages-of-an-insourced-dialysis-service-line-for-acute-care-facilities-using-outset-medical-s-tablor-hemodialysis-system) — Source: Outset Medical
- 2026-06-25 13:46 EST — [Outset Medical Reports Third-Quarter Results](https://biopharmsignal.com/news/OM/outset-medical-reports-third-quarter-results) — Source: Outset Medical
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)